PHG · REV 2026.10 For laboratory research use only. Not medical or dosing guidance.
Peptide Handling Guide Storage, handling and documentation for research peptides
Document
QA-04
Section
Documentation & quality
Revised
Sources checked

Analytical Testing Overview: Which Test Answers Which Question

Identity, purity, content, impurities and contaminants each need a different method. A map of the analytical techniques used for peptides and what each one can and cannot show.

2 min read

Bench card

  • No single test characterizes a peptide; identity, purity and content are separate questions.
  • HPLC answers "how pure?"; mass spectrometry answers "is it the right molecule?".
  • Amino acid analysis or nitrogen content answers "how much peptide is in the powder?".
  • Method validation shows that a test measures what it claims to, reliably.
  • Choose tests by the question you need answered, not by habit.

Peptide quality is not one number. Different tests answer different questions, and a certificate is only as informative as the tests it includes. This guide maps the common techniques to the questions they answer.

Question by question

Question Main techniques Limits
Is it the right molecule? Mass spectrometry; MS/MS sequencing Mass alone cannot distinguish isomers or some sequence swaps
How pure is it? Reversed-phase HPLC or UPLC with UV detection Only sees what elutes and absorbs at the chosen wavelength
What are the impurities? LC-MS Needs a capable lab and careful interpretation
How much peptide is in the powder? Amino acid analysis; nitrogen analysis Destructive; needs good calibration
How much water? Karl Fischer titration Small samples are hard to measure precisely
Which counterion, how much? Ion chromatography, NMR Rarely reported for research material
Is it the right stereochemistry? Chiral amino acid analysis Specialist test
Biological contaminants? Endotoxin (LAL), sterility, bioburden Only needed for specific applications

The core pair: HPLC and mass spectrometry

For most research peptides, reversed-phase HPLC and mass spectrometry together give a solid picture. HPLC separates the target from synthesis by-products such as deletion and truncated sequences, and estimates how much of each is present. Mass spectrometry confirms the target’s molecular mass and can identify impurities when coupled to HPLC (LC-MS). See HPLC Explained and Mass Spectrometry Explained.

Method validation

A test result is only useful if the method is fit for purpose. ICH Q2(R2) and USP <1225> define the characteristics that validation examines:

  • Specificity: the method distinguishes the analyte from impurities.
  • Accuracy and precision: results are close to the true value and repeatable.
  • Linearity and range: the response is proportional across the concentrations measured.
  • Detection and quantitation limits: how small an impurity can be seen and measured.
  • Robustness: small changes in conditions do not change the result.

Research suppliers rarely publish validation data, but asking whether a method is validated, and how, is reasonable.

What regulators look at for synthetic peptides

The FDA’s 2021 guidance on certain synthetic peptide generics shows how carefully impurities are treated in regulated products: it discusses identifying and characterizing new impurities at low levels relative to the reference product. Research material is not held to this standard, but the guidance is a useful reminder that a headline purity figure leaves a lot unsaid.

References

  1. ICH Q2(R2). Validation of Analytical Procedures. International Council for Harmonisation, 2023. ICH
  2. USP General Chapter <1225> Validation of Compendial Procedures. United States Pharmacopeia.
  3. USP General Chapter <621> Chromatography. United States Pharmacopeia.
  4. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422(6928):198–207. DOI
  5. Rutherfurd SM, Gilani GS. Amino acid analysis. Curr Protoc Protein Sci. 2009;Chapter 11:Unit 11.9. PubMed
  6. USP General Chapter <921> Water Determination. United States Pharmacopeia.
  7. US FDA. ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin. Guidance for Industry; 2021. FDA

Related guides

QA-05 HPLC Explained: How Peptide Purity Is Measured How reversed-phase HPLC separates a peptide from its impurities, how to read a chromatogram, and why the reported purity depends on the method. QA-06 Mass Spectrometry Explained: Confirming Peptide Identity How mass spectrometry weighs a peptide, how to read charge states and adducts on a spectrum, and the difference between average and monoisotopic mass. QA-07 Purity Terminology: Purity, Content, Counterions and Impurities Purity, net peptide content, peptide impurities, counterions and water are separate measurements that are often confused. A plain-language guide to what each term means.